Cargando…
Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study
The bacterium Pseudomonas aeruginosa is known to be associated with nosocomial infections around the world. Pazufloxacin, a potent DNA gyrase inhibitor, is known to be an effective drug candidate. However, it has not been clarified whether the pharmacokinetic (PK)/pharmacodynamic (PD) of pazufloxaci...
Autores principales: | Umezaki, Yasuhiro, Matsumoto, Kazuaki, Ikawa, Kazuro, Yokoyama, Yuta, Enoki, Yuki, Shigemi, Akari, Watanabe, Erika, Nakamura, Koyo, Ueno, Keiichiro, Terazono, Hideyuki, Morikawa, Norifumi, Takeda, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312304/ https://www.ncbi.nlm.nih.gov/pubmed/35884236 http://dx.doi.org/10.3390/antibiotics11070982 |
Ejemplares similares
-
Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto, Kazuaki, et al.
Publicado: (2016) -
Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including Acinetobacter baumannii
por: Onita, Tetsushu, et al.
Publicado: (2023) -
Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment
por: Yoshimura, Kosuke, et al.
Publicado: (2022) -
Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
por: Ishihara, Noriyuki, et al.
Publicado: (2020) -
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
por: Kohama, Hanako, et al.
Publicado: (2017)